Combination Therapy with a Dipeptidyl Peptidase-4 Inhibitor, Sulfonylurea, and Metformin Markedly Improves HbA1c Levels in Japanese Patients with Type 2 Diabetes Mellitus

Combination Therapy with a Dipeptidyl Peptidase-4 Inhibitor, Sulfonylurea, and Metformin Markedly Improves HbA1c Levels in Japanese Patients with Type 2 Diabetes Mellitus

Combination therapy with a dipeptidyl peptidase (DPP)-4 inhibitor and metformin or sulfonylurea results in substantial and additive glucose-lowering effects in patients with type 2 diabetes mellitus (T2DM). However, it is not known whether triple combination therapy with a DPP-4 inhibitor, metformin...

Full description

Bibliographic Details
Main Authors: Hirao, Koichi, Maeda, Hajime, Shirabe, Shin-ichiro, Yamamoto, Ritsuko, Hirao, Tetsuyuki, Hirao, Setsuko, Yamauchi, Mikio, Arai, Keiko
Format: Online
Language:English
Published: Libertas Academica 2012
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3738556/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3738556/

Similar Items